CN
CN
Our latest
Creative Biosciences
Lunsafe® Wins NMPA Approval, Pioneering Noninvasive Early Detection of Lung Cancer in China

Guangzhou, China – May 30, 2025 – Creative Biosciences (Guangzhou) CO., Ltd. today announced that its independently developed methylation test kit for the early detection of lung cancer, Lunsafe, has received official approval from China’s National Medic

Jun 01 , 2025
Media Coverage
Authoritative media releases


Read more
Press releases
Lunsafe® Wins NMPA Approval, Pioneering Noninvasive Early Detection of Lung Cancer in China
Jun 01 , 2025
Creativebio Made Debut Presence at Life Science Innovation Northwest 2025
May 06 , 2025
Creative Biosciences Expands Global Footprint with New Seattle Branch
Mar 21 , 2025
One Million Tests of Colosafe Realized in Real World Practice
Feb 20 , 2025
CreativeBio Is Exhibiting at MEDICA 2022
Nov 15 , 2022
Colosafe® Gained Market Entry in Mexico
Jan 23 , 2025
CreativeBio,the Leading Enterprise in Cancer Screening,Completed Rd D Venture Capital Financing of RMB 560 Million Led by Alibaba
Oct 20 , 2021
Creative Biosciences Shines at MEDICA 2024 in Germany, Accelerating Its Global Market Expansion
Nov 14 , 2024
Colosafe Was Showcased at the 46th Mexican National Clinical Chemists Conference in Mecixo City
Sep 15 , 2024
Colosafe® Showcased in the National "13th Five-Year" Scientific and Technical Innovation Achievement Exhibition
Nov 02 , 2021
Marvelous News! Creative Biosciences Won the National-Level Title of "Little Giant" Enterprise in the Category of Specialization, Refinement, Differentiation, and Innovation.
Sep 07 , 2024
Colosafe® Gains Market Entry in Brazil--Groundbreaking in South America!
Sep 04 , 2024

No. 10 Fenghuang Wu Road
Huangpu District
Guangzhou, Guangdong, 510555
P.R. China


Contact us at

T: +001-206-717-2769
Email: info@creativebio.cn


copyright ©2025 Creative Biosciences (Guangzhou) CO., Ltd
Legal mention